According to the American Cancer Society, roughly 1 in 8 men will be diagnosed with prostate cancer at some point in their lives. The good news is that for many men – particularly those who are diagnosed early – prostate cancer is highly manageable, and survival rates are strong. Understanding your options is one of the most powerful steps you can take.
A prostate cancer diagnosis changes everything in an instant. One moment, life is moving along as usual. The next, you’re sitting in a doctor’s office absorbing information that feels too big, too confusing, and too frightening to fully process. If you’re the one who was just diagnosed, or if you’re a family member or caregiver trying to help a loved one navigate their diagnosis, the flood of decisions ahead can feel paralyzing.
Among the most significant of those decisions is choosing a treatment path, but before you head down that road, there is one significant factor to understand from the start: Prostate cancer treatment is not one-size-fits-all. There is rarely one right approach to a treatment plan. The best course of action depends on a combination of medical factors that are unique to each patient.
This guide is written for anyone navigating the decisions that accompany a prostate cancer diagnosis. Whether you’re the patient, a spouse or partner, an adult child, or a close friend trying to provide meaningful support, this guide will help you understand your options, including:
Before thinking about treatment, it helps to understand your diagnosis and prognosis. The details of the diagnosis will serve as a foundation for building your treatment plan.
For most men, a prostate cancer diagnosis begins with a PSA (prostate-specific antigen) test – a routine blood test that measures the level of PSA, a protein produced by the prostate gland. Elevated PSA levels can indicate the presence of cancer, though they can also be caused by other conditions. PSA testing is an essential screening tool, especially for men over 50 or those in higher-risk groups.
If a PSA result raises concern, the next step typically involves additional testing, which may include imaging (MRI or ultrasound) and a biopsy. The biopsy results include a Gleason score, which indicates how aggressive the cancer appears under a microscope. Pathologists assign a grade to the two most common patterns of cancer cells found in the sample, then add them together to produce the Gleason score. For example, a Gleason score of 7 (3+4) means the most prevalent cells were graded 3 and the second most prevalent were graded 4. Higher scores indicate more aggressive cancer; lower scores suggest slower-growing disease.
Today, Gleason scores are often translated into grade Groups on a scale of 1 to 5, which can be easier to interpret: grade Group 1 represents the least aggressive cancer, while grade Group 5 represents the most aggressive. This score plays a central role in shaping treatment recommendations. PSA levels, imaging findings, and whether the cancer has spread to other parts of the body will also influence treatment recommendations.
As prostate cancer develops, it may remain confined to the prostate gland or grow beyond it over time. When cancer has not spread outside the prostate, treatment options are typically the broadest, and long-term outcomes are most favorable. As the disease progresses, it may extend beyond the prostate to nearby tissue, lymph nodes, or other parts of the body, which generally calls for more systemic treatment approaches.
Most men diagnosed with prostate cancer are diagnosed before significant spread has occurred, which is one of the strongest arguments for routine screening.
Understanding the factors that contribute to a prostate cancer diagnosis can help with conversations around early and routine screening, genetic screening, preventative treatment conversations, and family awareness.
Key risk factors include:
For patients newly diagnosed with localized disease especially, the range of options can feel both reassuring and overwhelming. One of the most striking aspects of prostate cancer care is the number of treatment paths available, and the number of therapies that are still being studied.
Below is an overview of treatments to discuss with your doctor, depending on your prognosis. Your doctor may also be aware of other treatment options as newer research continues to develop.
For men with low-risk, slow-growing cancers, active surveillance offers a way to monitor the cancer closely without immediate intervention or invasive treatment. This involves regular PSA tests, periodic biopsies, and imaging to track any changes. active surveillance can spare patients from treatment side effects, but it does require consistent follow-up and a degree of emotional comfort with watchful waiting.
Surgical removal of the prostate gland is one of the most common approaches for localized prostate cancer. Today, many procedures are performed using minimally invasive surgical techniques that have improved precision and recovery times. Surgery aims to remove the cancer entirely. However, be sure to speak with your doctor about potential post-surgery side effects.
This approach uses high-energy beams directed at the prostate from outside the body. Modern techniques, such as intensity-modulated radiation therapy (IMRT), allow for precise targeting that minimizes impact on surrounding tissue. external beam radiation Therapy (EBRT) is typically delivered over multiple sessions, though newer protocols can condense the overall course of treatment.
brachytherapy involves placing radioactive sources directly inside or near the prostate gland. Low Dose Rate (LDR) brachytherapy uses permanently implanted seeds that emit low levels of radiation over time. High Dose Rate (HDR) brachytherapy temporarily implants the radiation source and uses a stronger dose each session. Both approaches can be highly effective for appropriately selected patients.
A specialized form of radiation, proton beam therapy delivers radiation precisely to the tumor while minimizing exposure to nearby healthy tissue. Because the treatment is so precise and the protons dissipate soon after reaching the cancer cells, it can take a bit longer than other radiation treatments.
HIFU uses focused ultrasound energy through the rectum to destroy prostate tissue. It is a minimally invasive option that may be appropriate for certain patients, though it is less broadly available and has less long-term data available than some other approaches.
Cryotherapy involves using extremely cold gases to freeze and destroy prostate tissue. It may be used as a primary treatment or as a salvage therapy when other treatments have not achieved the desired result.
Because prostate cancer cells typically rely on male hormones (androgens) to grow, hormone therapy works by reducing androgen levels or blocking their effects. It is commonly used in combination with radiation for higher-risk cases and as a treatment for advanced or metastatic disease. When used in lower-risk cases, it may be used to decrease the size of the prostate gland prior to other treatments.
While not a first-line treatment for localized prostate cancer, chemotherapy may be used for advanced or metastatic disease, often alongside hormonal therapy.
It’s also worth knowing that emerging therapies — including immunotherapy, targeted therapy, and newer radiopharmaceutical treatments — are actively being studied and, in some cases, already approved for certain patients. Clinical trials represent an additional avenue worth exploring for those who qualify.
There is no one-size-fits-all option for choosing a prostate cancer treatment. While patients will ask which treatment is the most effective, the answer is often nuanced. This is why having a conversation with a specialist is so important.
An effective treatment outcome may also have a different meaning from one person to the next. While some patients may want to focus on outcomes, others may want to focus on side effects and quality of life.
It’s important to note that each treatment path may have differing potential side effects, and those side effects can meaningfully affect day-to-day life. Understanding these trade-offs is essential to making an informed choice.
Potential side effects from prostate cancer treatment should not be ignored or pushed aside. They are medical issues that benefit from empathy, support, and professional care, as they can drastically impact the patient’s overall well-being, mental health, and relationships.
Knowing how to choose a prostate cancer treatment is not purely a clinical calculation with a singular answer. It is a deeply personal decision shaped by medical, diagnostic, and personal factors.
When recommending a course of treatment, the following considerations will likely come into play:
The stage of the cancer, its Gleason score or grade Group, and PSA levels form the medical foundation of any treatment decision. A very low-risk cancer may be well-managed with active surveillance or surgery, while a higher-risk cancer may call for more aggressive intervention.
A younger man in excellent health may weigh long-term recurrence risk more heavily than a man in his 80s with other significant health conditions. Someone who is already in poor health may not want to take on the additional side effects that can accompany certain treatment options.
This is where conversations become more personal. Some men place the highest value on achieving the most complete possible removal of the cancer. Others prioritize preserving sexual function, avoiding invasive procedures, or minimizing disruption to work and daily life.
Some treatments, particularly less common or more specialized, may only be available at dedicated healthcare facilities. Treatment schedules are also a consideration: A course of radiation that requires daily appointments for two months may not be feasible, whether due to financial, employment, or geographical factors. These practical realities are worth discussing with the care team.
Receiving a prostate cancer diagnosis can be a lot to take in. For low-risk cancers especially, there is often time to gather information, seek additional opinions, and allow the initial shock of the diagnosis to settle before committing to a path. Taking that time is not avoidance – it is part of making a good decision when the diagnosis allows for it.
Treatment costs and coverage vary depending on a person’s financial or insurance situation, making financial considerations a legitimate part of the equation for many families. Social workers and patient navigators at cancer centers and certain hospitals can often help identify assistance programs and financial resources.
One of the most important things you can do when facing a prostate cancer diagnosis is to build a care team that values your trust and comfort. When navigating a prostate cancer diagnosis, you may find yourself with a multidisciplinary team of practitioners, such as a urologist, a radiation oncologist, and sometimes a medical oncologist (particularly for advanced disease). You will likely also interact with nurses, social workers, and patient navigators.
Different specialists may offer different perspectives on the best path forward, reflecting both the evidence and their areas of expertise. Remember: Hearing more than one clinical view is not disloyal to any physician. It’s how thorough, patient-centered decisions get made.
A second opinion may confirm the initial recommendation and give the patient added confidence. Or it may introduce options or considerations that weren’t raised the first time. Second opinions are especially valuable for complex cases, high-risk diagnoses, or whenever a patient or family member feels uncertain about the recommended path.
When consulting specialists, it helps to arrive with specific questions. Here are a few examples of questions to ask, especially if you don’t know where to start.
Consider bringing a family member or trusted friend to appointments. The emotional intensity of these conversations makes it easy to miss or forget important details in the moment. A second set of ears, in addition to someone who can help take notes and ask follow-up questions, can make a real difference.
The emotional and social dimensions of a prostate cancer diagnosis are just as real as the clinical ones, and they deserve real support. Here are a few ways you can help support yourself (or others, if you’re a caregiver) throughout a prostate cancer diagnosis and treatment:
PCFC hosts support groups designed to connect patients and families with community resources, expert guidance, and peer connections to help mitigate feelings of isolation. Groups are held the first Wednesday of the month at Wellness House in Hinsdale, Illinois, and available virtually as well.
Anxiety and depression are common among both patients and caregivers during a prostate cancer diagnosis. Many cancer centers, including Wellness House, have mental health professionals who specialize in working with patients and their families.
A diet rich in vegetables, fruits, and whole grains may support overall health during and after treatment. Wellness House provides access to nutrition programs that include cooking classes and side-effect management.
A growing body of research supports the value of regular physical activity in reducing treatment-related fatigue and supporting mental well-being. Cancer centers like Wellness House provide access to movement and strength classes to help increase energy and reduce side effects from treatment. Sleep and stress management are equally important and often underestimated.
Reliable information matters more than most people realize. Not everything available online about prostate cancer is accurate, current, or applicable to a specific situation. When researching, lean on established organizations, peer-reviewed sources, and the guidance of the care team. Bring questions from your research directly to a specialized medical professional rather than acting on information without clinical context.
There is something uniquely powerful about hearing from someone who’s walked in your shoes and can relate to your experience. Medical information matters deeply, but relatable human stories carry a different kind of weight. They offer perspective, encouragement, and a sense of possibility that statistics and clinical summaries alone cannot provide.
Real accounts from prostate cancer patients and survivors help those facing a new diagnosis understand what life during and after treatment looks like. A survivor who describes how they weighed their options, managed side effects, or found their way back to a fulfilling life offers a perspective no brochure can: evidence that getting through this is possible.
Patient stories also illuminate the emotional terrain that accompanies a diagnosis: the fear before a biopsy, the difficulty of telling family members, the relief of finding a doctor who truly listened. These are the dimensions of a prostate cancer journey that matter deeply to the people living through them.
When using patient stories as a support system, look for experiences from people whose diagnosis, risk level, and priorities are similar to yours or your loved one’s. Shared context makes these accounts especially resonant.
There is no universally correct way to choose prostate cancer treatment. Knowing how to choose prostate cancer treatment means accepting that the right answer is the one that best fits a specific person’s cancer, overall health, values, and life circumstances. That’s why the decision-making process works best as a true dialogue between the patient and other people in their circle, including family and physicians.
For patients and families in the Chicago area, the Prostate Cancer Foundation of Chicago (PCFC) is here as a local partner and trusted resource. From informational meetings and community support groups to connections with local specialists, the PCFC’s mission is to be your friend in Chicago when prostate cancer touches your life or the life of someone you love. Learn more about how we can help after your diagnosis, and visit the PCFC News & Blog for ongoing resources and updates.
Remember: You don’t have to figure this out alone.
When someone you care about receives a prostate cancer diagnosis, your immediate instinct may be…
For many men, conversations about prostate health begin with screening questions. One of the most…
Loyola University Chicago Announces Establishment of the Brian J. Moran, M.D. Radiation Oncology Research &…
August 14 - Ella's Italian Pub Dine Out on Thursday, August 14 at Ella's Italian…
We send our deepest condolences to the family of Ryne Sandberg. Sandberg announced in January…
Female Friday Funday Floatday was on 7/11/2025. The 8th annual FFFF had 700 women come out…